主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CALC
#3866
CalciMedica, Inc. Common Stock
0.5
2
-7.14%
版块:
基础:
利润货币:
日范围
年范围
日变化
-7.14%
每月变动
-38.10%
6个月变化
-82.07%
年变化
-78.78%
前一天收盘价
0.5
6
Open
0.5
2
Bid
Ask
Low
0.5
2
High
0.5
2
交易量
4
市场
股票
医疗保健
CALC
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
13.48 M
13.48 M
13.97 M
13.97 M
14.26 M
—
Valuation ratios
Enterprise value
50.57 M
39.79 M
14.13 M
16.44 M
—
—
Price to earnings ratio
0.26
-2.9
-1.16
-0.96
-1.86
-6.89
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
1.92
1.88
1.05
0.97
1.99
5.89
Price to book ratio
0.79
2.76
0.47
0.49
1.24
4.96
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.33
-0.22
-0.2
-0.31
-0.52
-1.25
Return on equity %
0.59
-0.3
-0.46
-0.98
-29.12
-30.85
Return on invested capital %
-2 013.51
-2 593.28
-3 244.44
-3 917.75
-2 623.7
-12.38 K
Gross margin %
—
—
100
100
100
—
Operating margin %
—
—
-3 216.34
-3 009.55
-4 012.86
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
-2 496.04
-2 707.27
-5 574.29
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
4.15
5.34
5.66
5.45
4.04
20.48
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
—
0.01
0.01
0.01
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.44
-0.44
-0.35
-0.46
-0.32
-1.57
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
1.37
1.66
1.74
1.24
0.96
5.6
Net current asset value per share
1.47
1.75
1.79
1.3
1.01
5.84
Tangible book value per share
0.85
1.28
0.77
0.42
-0.02
2.45
Working capital per share
1.12
1.42
1.47
1.06
0.76
4.71
Book value per share
0.85
1.28
0.77
0.42
-0.02
2.45
新闻
H.C. Wainwright将CalciMedica股票评级下调至中性,因试验暂停
CalciMedica stock downgraded to Neutral by H.C. Wainwright after trial halt
CalciMedica因委员会建议终止二期KOURAGE临床试验
CalciMedica discontinues Phase 2 KOURAGE trial following committee recommendation
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.02%
美国股市涨跌不一;截至收盘道琼斯工业平均指数上涨0.02%
CalciMedica股价因终止肾损伤试验而暴跌
CalciMedica因安全担忧终止急性肾损伤试验
CalciMedica discontinues AKI trial following safety concerns
CalciMedica Pauses Kidney Study, Eyes New Trial In Pancreatitis - CalciMedica (NASDAQ:CALC)
Oppenheimer reiterates Outperform rating on CalciMedica stock ahead of key trial
CalciMedica partners with Telperian to use AI for clinical trial analysis